Replies to post #223926 on Biotech Values

[DewDiligence]

ENTA—The existence of a 10b5-1 plan for the General Counsel (which generated the sale on 2/13/19) makes the fairly large exercise-and-hold transactions cited in #msg-147373277 even more noteworthy, IMO.